Sophia Genetics SA
NASDAQ:SOPH
Sophia Genetics SA
SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.
SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.
Revenue Growth: SOPHiA GENETICS delivered Q3 revenue of $19.5 million, up 23% year-over-year, marking a third consecutive quarter of accelerating growth.
Guidance Raised: Management raised full-year 2025 revenue guidance to $75–77 million (from $72–76 million), citing strong business momentum.
Gross Margin: Gross margin was 66.3% in Q3, with adjusted gross margin holding strong at 73.1%, despite significant increases in data volume.
Biopharma Recovery: Biopharma revenues returned to growth, with AstraZeneca as a key partner; the pipeline is described as stronger than ever.
Customer Expansion: 31 new customers signed in Q3 (up from 22 last year); total new accounts in 2025 already surpass last year’s total.
Liquid Biopsy Ramp: MSK-ACCESS liquid biopsy adoption accelerated, with over 60 customers signed and triple-digit analysis volume growth.
Operating Expense Control: Operating expenses remained mostly flat on a constant currency basis, demonstrating operating leverage despite some temporary cost headwinds.
Implementation Backlog: Backlog of new customer implementations remains at record levels, providing strong forward revenue visibility.
